Looking at Q3, Cantel Medical (NYSE: CMD ) earned $45.52 million, a 43.93% increase from the preceding quarter. Cantel Medical also posted a total of $313.95 million in sales, a 6.77% increase since Q2. Cantel Medical earned $31.63 million, and sales totaled $294.04 million in Q2. What Is Return On Capital Employed? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company''s ROCE. A higher ROCE is generally representative Full story available on Benzinga.com
A report was released recently that sheds lots of light on the Endoscope Reprocessing Solution Industry. The report covers an overview of the industry along with a detailed explanation that provides a lot of insight. The report also analyzes the production as well as management technology in various end-user industries. An in-depth study in some []
The Market Abstract of Hemodialysis Market The Hemodialysis market report is designed to include both qualitative and quantitative aspects of the business in globally each region and country participating in the study. The report also offers detailed information on important features
Analytical Filter Papers Market report offers an overall scope of the market which includes future supply and demand scenarios, changing market trends, high growth opportunities, and in-depth analysis of the future prospects of the market. The report discusses the competitive
Earnings results for Cantel Medical , Analyst Opinion on Cantel Medical , Earnings and Valuation of (NYSE:CMD), Stock market Insights & financial analysis, Best stock to invest, Investment Idea, The post Earnings and Growth Analysis : Cantel Medical (NYSE:CMD) appeared first on .
Cantel Medical LLC, formerly known as Cantel Medical Corp., announced that it has delivered a notice to holders of its 3.25% Convertible Senior Notes due 2025, pursuant to the indenture governing the Notes, notifying holders that, as a result of each of the consummation of the series of mergers contemplated by the Agreement and Plan of Merger, dated as of January 12, 2021
DUBLIN, IRELAND, June 02, 2021 (GLOBE NEWSWIRE) STERIS plc (NYSE: STE) (STERIS or the Company) today announced that it View post on CompanyNewsHQ : STERIS Completes the Acquisition of Cantel Medical | STERIS plc
STERIS plc (NYSE: STE) (STERIS or the Company) today announced that it has completed the previously announced acquisition of Cantel Medical, a global provider of infection prevention products and services to endoscopy, dental, dialysis and life sciences Customers.
The Global Hand And Surface Disinfectants Market report provides a detailed analysis of the dynamic research on the current situation of the market size, share, demand, development patterns, and forecast in the coming years (2021-2025). The Hand And Surface Disinfectants Market analyzes
Dublin, May 28, 2021 (GLOBE NEWSWIRE) -- The "Endoscope Reprocessing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com''s offering. Amid the COVID-19 crisis, the global market for Endoscope Reprocessing estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$2.9 Billion by 2027, growing at a CAGR of 7.3% over the analysis period 2020-2027.
The report examines the Dialyzer Reprocessing Machines And Concentrates market in depth, outlining the market''s growing trends and dynamics. The purpose of the research is to assist readers in making an accurate assessment of current and future market scenarios. During
Epidemic Disease Infection Control Solution Market Size, Status and Forecast 2020-2025 Global Epidemic Disease Infection Control Solution market 2019-2025 in-depth study accumulated to supply latest insights concerning acute options. The report contains different predictions associated with Epidemic Disease Infection Control Solution market size, revenue, production, CAGR, consumption, profit margin, price, and different substantial factors. Whereas []
Cantel Medical Corp (CMD) shares closed today at 1.1% below its 52 week high of $89.76, giving the company a market cap of $3B. The stock is currently up 11.5% year-to-date, up 165.1% over the past 12 months, and up 27.8% over the past five years. This week, the Dow Jones Industrial Average fell 0.4%, and the S&P 500 rose 0.1%. Trading Activity Trading volume this week was 58.2% higher than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 1.5. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -12.9% The company's stock price performance over the past 12 months beats the peer average by 224.2% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -438.9% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
NEW YORK , April 16, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq. WeissLaw LLP 1500 Broadway, 16 th Floor New York , NY 10036 (212) 682-3025 (888) 593-4771 stockinfo@weisslawllp.com Cantel Medical Corp. (NYSE: CMD ) WeissLaw LLP is investigating possible breaches of fiduciary … Full story available on Benzinga.com
NEW YORK, March 11, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Cantel Medical Corp. (NYSE: CMD) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating…
Companies Reporting Before The Bell • Barnes & Noble Education (NYSE:BNED) is expected to report quarterly loss at $0.38 per share on revenue of $397.48 million. • Cantel Medical (NYSE:CMD) is estimated to report quarterly earnings at $0.50 per share on revenue of $276.63 million. • Dick’s Sporting Goods (NYSE:DKS) is projected to report quarterly… Read More »Earnings Scheduled For March 9, 2021
NEW YORK , Feb. 10, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq. WeissLaw LLP 1500 Broadway, 16 th Floor New York , NY 10036 (212) 682-3025 (888) 593-4771 stockinfo@weisslawllp.com Cantel Medical Corp. (NYSE: CMD ) WeissLaw LLP is investigating possible breaches of fiduciary … Full story available on Benzinga.com
NEW ORLEANS, Feb. 9, 2021 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Cantel Medical Corp (NYSE: CMD) to STERIS plc (NYSE: STE). Under the terms of the proposed…
Needham Stick to Their Buy Rating for Cantel Medical Corp
Treating you—and your story—with courtesy and care. Our commitment to delivering the best personal service defines our business and inspires our efforts every day. We’re accessible and responsive to every client we serve, using cutting-edge technology and innovation makes it easier for us to focus on relationship building. The way we see it, a helpful… Read More »Investor Acquires Shares of Commander Resources Ltd.
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Cantel Medical Corp (NYSE: CMD) to STERIS plc (NYSE: STE). Under the terms of the proposed transaction, shareholders of Cantel will receive only $16.93 in cash and 0.33787 of a STERIS ordinary share for each share of Cantel that they own. KSF is seeking to determine whether this consideration and the process t
NEW YORK, Jan. 13, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Cantel Medical Corp. ("CMD" or the "Company") (CMD) relating to its…
NEW YORK, Jan. 13, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Cantel Medical Corp. (NYSE: CMD) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating…
Jones Day is advising medical equipment company Steris Plc in its $4.6 billion acquisition of Cantel Medical Corp, which is being represented by Wachtell, Lipton, Rosen & Katz. Cantel's financial adviser, Centerview Partners, turned to Weil, Gotshal & Manges for legal advice…
Steris sells products and services to sterilize surgical instruments and operating rooms as well as research labs.
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether Cantel Medical Corp. (NYSE: CMD) and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Cantel to STERIS plc. Under the terms of the merger agreement, Cantel shareholders will receive approximately $16.93 in cash and 0.33787 of a STERIS ordinary share per Cantel common share. On behalf of
Needham Stick to Their Buy Rating for Cantel Medical Corp
iBio (NYSE: IBIO ) shares … Full story available on Benzinga.com
LITTLE FALLS, N.J., Dec. 8, 2020 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced financial results for its first quarter ended October 31, 2020. First quarter 2021 net sales were $297.0M, up 15.5% compared to the prior year. Excluding the impact from foreign currency, net…
LITTLE FALLS, N.J. , Dec. 7, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP . (NYSE: CMD ) and Censis Technologies announced today a new long-term partnership to combine Cantel's leading infection prevention endoscope reprocessing workflow portfolio with the surgical asset management and instrument tracking solutions from Censis. The new enhanced, co-branded software solution will combine the CANEXIS™ Integrated Workflow Solution for Endoscopy from Cantel with Censis' CensiTrac® surgical asset management software to create the leading instrument reprocessing and scope tracking software available to the market. Leveraging Censis' strengths in software development, cloud-based technology, and professional services and support with the leading position in endoscope reprocessing and infection prevention from Cantel, the combined solution will support endoscopy customers with best-in-class quality management tools, providing peace of mind and confidence that their facility is executing best practices to support patient …
What Sort Of Returns Would Cantel Medical's(NYSE:CMD) Shareholders Have Earned If They Bought Their SharesThree Years In the past? -
LITTLE FALLS, N.J., Nov. 24, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its first quarter ended October 31, 2020 on Tuesday, December 8, 2020 before the market opens, and hold a conference call to discuss the results at 8:30 a.m. ET. To participate…
Global Medical Device Outsourcing Market report brings into light key market dynamics of the sector. It provides guidelines about planning of advertising and sales promotion efforts. The market report is a professional yet exhaustive study on the current state for
Industrial Growth Forecast Report Automated Endoscopy Reprocessor Market 2020-2027: The Global Automated Endoscopy Reprocessor Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Automated Endoscopy Reprocessor Market business, including market dynamics, segmentation,
Real-Time News, Market Data and Stock Quotes For Junior Mining Stocks.
The report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast
The Latest research study released by the Insight Partners on “Disinfectants Market ” The report contains in-depth information on all the key aspects of the global Disinfectants Market . This report contains data such as facts & figures, market research,
Cantel Medical (NYSE:CMD) will post its quarterly earnings results on Sunday, October 25th. Analysts expect Cantel Medical to post earnings of ($0.01) per share for the quarter. Cantel Medical stock opened at $51.82 on Friday. The company has a market cap of $2.18 billion, a price-to-earnings ratio of 126.39, a PEG ratio of 11.67 and […]
Kidney dialysis centers market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to growth at a CAGR of 3.3% in the above-mentioned forecast period. The rising
LITTLE FALLS, N.J., Oct. 22, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) announced an estimated revenue range for the company's first fiscal quarter, ending on October 31st, 2020, of $290 - $295 million, an increase of approximately 25% sequentially from the prior quarter, a…
The winning Offsite Sterilization Services Market report makes available the current and forthcoming technical and financial details of the industry. Few of the chief insights of this business report include; distinct analysis of the market drivers & restraints, major market
This comprehensive report gives significant insights into the Sterilization Validation Service market at global, regional and individual company levels. Various factors like market size, market growth rate, submarkets, the compounded annual growth rate (CAGR) and the production and consumption capacities
LITTLE FALLS, N.J., Oct. 1, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP (NYSE:CMD) announced today that Michael Drexel has been hired as Senior Vice President and Chief Technology Officer reporting to George Fotiades, Chief Executive Officer. Michael is based in Plymouth, Minnesota. Mr….
Cantel Medical Corp. (NYSE:CMD) Q4 2020 Earnings Conference Call September 17, 2020, 08:30 AM ET Company Participants Matt Micowski - VP, IR and Financial Planning and Analysis George Fotiades - President and CEO Shaun Blakeman - SVP and CFO Peter Clifford - EVP and COO Seth Yellin - EVP, Strategy and Corporate Development Conference Call Participants Larry Keusch - Raymond James Matthew Mishan - KeyBanc Capital Markets Mitra Ramgopal - Sidoti & Company Mike Matson - Needham & Company Presentation Operator Hello, everyone, and thank you for joining us today, for this Cantel Medical Fourth Quarter 2020 Earnings Call.
LITTLE FALLS, N.J., Sept. 17, 2020 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced financial results for its fourth quarter ended July 31, 2020. Fourth quarter 2020 net sales were $233.4M, down 2.5% compared to the prior year. Excluding the impact of foreign currency, net…
Companies Reporting Before The Bell • Apogee Enterprises (NASDAQ: APOG ) is projected to report quarterly earnings at $0.30 per share on revenue of $314.73 million. • Cantel Medical (NYSE: CMD ) is expected to report … Full story available on Benzinga.com
Cantel Medical (NYSE:CMD) is scheduled to announce FQ4 earnings results on Thursday, September 17th, before market open. The consensus EPS Estimate is -$0.
LONDON--(BUSINESS WIRE)-- #GlobalSutureNeedlesMarket--The Global Suture Needles Market will grow by $ 73.50 mn during 2020-2024
LITTLE FALLS, N.J., Sept. 3, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its fourth quarter ended July 31, 2020 on Thursday, September 17, 2020 before the market opens, and hold a conference call to discuss the results at 8:30 a.m. ET. To participate…
DUBLIN--(BUSINESS WIRE)--The "Global Disinfectant Sprays and Wipes Market 2019-2028" report has been added to ResearchAndMarkets.com's offering. After a detailed analysis, the publisher has concluded that, the global disinfectant sprays and wipes market will display an upward trend and grow at a CAGR of 6.54% in terms of revenue over the forecast period of 2019 to 2028. The growing emergence of unknown pathogens, rising complications arising due to healthcare-associated infections, and advancem
- ← Previous
- 1
- 2
- Next →